Replies to post #14930 on Innovus Pharmaceuticals Inc. (fka INNV)

[healthywelth]

never, said , never.......

[jtaylor68]

Yes, they've had plenty of product launches which are naturally very expensive. Also, the entire Fluticare batch was booked in this quarter. This is all explained in the filings. You should read them.

Expenses will come down once the majority of products have been fully integrated into the BH platform.

[Drugdoctor]

LMAO - 81% GROSS MARGINS are TRUE!

Of course I know everyone saw this, but I'll post it once more since it's such a FANTASTIC NUMBER!! Just look for the UNDERLINED PART...

And of course I have a link...

https://finance.yahoo.com/news/innovus-pharmaceuticals-reports-record-quarterly-200500208.html

Financial highlights for the three months ended March 31, 2018 included:

Net revenues totaled $4.5 million for the three months ended March 31, 2018 compared to net revenues of $2.2 million for the three months ended December 31, 2016 representing a 108.7% increase.
Sequential quarter over quarter revenue increase of 91.0% in the first quarter 2018 compared to an increase of 28.7% in the first quarter 2017.
Gross margins increased to 81% for the three months ended March 31, 2018 compared to 80% the same three-month period in 2017.
Total cash on hand close to $5 million at March 31, 2018

Next...